Overview

Minocycline Treatment in Retinitis Pigmentosa

Status:
Recruiting

Trial end date:
2023-12-01

Target enrollment:

Participant gender:

Summary

The aim of this study is to evaluate the efficacy and safety of oral minocycline (100mg/d), administered for 6 months, for the treatment of patients with retinitis pigments(RP).

Phase:

Phase 2

Details

Lead Sponsor:

Sun Yat-sen University

Treatments:

Minocycline